Disc Medicine (IRON) Prepaid Assets (2020 - 2026)
Disc Medicine (IRON) posted quarterly Prepaid Assets of $15.0 million for Q2 2026, up 29.23% year-over-year from $11.6 million in Q2 2025, and down 13.19% quarter-over-quarter from $17.3 million in Q1 2026.
Analysis
Disc Medicine (IRON) Prepaid Assets (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Prepaid Assets for 7 consecutive years, with $15.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Prepaid Assets rose 29.23% year-over-year to $15.0 million; the TTM figure through Jun 2026 stood at $15.0 million (up 29.23% YoY), while the FY2025 annual figure was $12.7 million, up 241.35% from the prior year.
- Prepaid Assets retreated to $15.0 million in Q2 2026 per IRON's latest filing, from $17.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $17.3 million in Q1 2026 and bottomed at $2.9 million in Q3 2022.
- Historically, Prepaid Assets has averaged $7.8 million across 5 years, with a median of $5.8 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 38.13% — and 2025, when it jumped 241.35%.
- Disc Medicine's Prepaid Assets stood at $3.9 million in 2022, then soared by 36.08% to $5.3 million in 2023, then declined by 29.28% to $3.7 million in 2024, then surged by 241.35% to $12.7 million in 2025, then increased by 17.8% to $15.0 million in 2026.
- Business Quant data shows IRON's Prepaid Assets at $15.0 million in Q2 2026, $17.3 million in Q1 2026, and $12.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.02 Mn |
| Mar 31, 2026 | 17.30 Mn |
| Dec 31, 2025 | 12.75 Mn |
| Sep 30, 2025 | 11.25 Mn |
| Jun 30, 2025 | 11.62 Mn |
| Mar 31, 2025 | 10.94 Mn |
| Dec 31, 2024 | 3.73 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 9.33 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 3.72 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 5.72 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 4.47 Mn |
| Mar 31, 2022 | 4.68 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | 4.73 Mn |